Design in Public Production of Medicines

When the Objective is a Social Asset

Authors

  • María Gabriela Madonia Facultad de Artes. Universidad Nacional de La Plata

DOI:

https://doi.org/10.24215/25249703e012

Keywords:

State, design, technology, production, health

Abstract

This article is an analytical approach to an interdisciplinary work carried out in 2012. The purpose is to rethink general guidelines for the development of products aimed at supplying certain drugs in state policy. In this sense, the theoretical framework that is intended to be developed lies in the tension between the formal model with which it is usually designed in the pharmaceutical industry and the differences and regularities inherent in the construction of own concepts for the social task carried out by the State. The fundamental hypothesis is based on the idea that political-ideological differences also determine specific lines of intervention for the designer.

Downloads

Download data is not yet available.

References

Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT). (6 de febrero de 2012). Disposición 0753 de 2012. Recuperado de http://www.anmat.gov.ar/comunicados/Disposicion_0753-2012.pdf

Chaves, N. y Belluccia, R. (2003). La Marca Corporativa. Gestión y diseño de símbolos y logotipos. Ciudad Autónoma de BuenosAires, Argentina: Paidós.

Moreno Fernández-Caparrós, L. A. (2 de febrero de 2015). La cruz azul cumple cien años. Recuperado de https://www.historiaveterinaria.org/update/cruz-azul-145629284.pdf

Ventura, A. (15 de noviembre de 2013). La cruz: simbología y marcas médicas [Entrada de blog]. Recuperado de http://www.marketingmedico.com/2013/11/15/la-cruz-medica-simbolo-
del-sector/

Published

2020-10-21

How to Cite

Madonia, M. G. (2020). Design in Public Production of Medicines: When the Objective is a Social Asset. Bold, (7), e012. https://doi.org/10.24215/25249703e012

Issue

Section

Opinión